Manufacturers Service

DIAGENODE SA

rue du Bois st Jean 3 , 4102 Seraing
Belgium

Telephone +32 4 3642050
Fax +32 4 3642051
info@diagenodediagnostics.com

This company is co-exhibitor of
AWEX - Wallonia Export & Investment

Trade fair hall

  • Hall 3 / K74
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 3): stand K74

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.02  DNA diagnosis kits

DNA diagnosis kits

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases

Auto-immune diseases

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.03  Auto-immune diseases
  • 03.02.03.02  Diagnostics / kits for the gastro enterology

Diagnostics / kits for the gastro enterology

  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.05  Equipment and systems for microbiological diagnosis/virology

Equipment and systems for microbiological diagnosis/virology

  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.05  Equipment and systems for microbiological diagnosis/virology
  • 03.05.05.01  Diagnostic agents / kits for microbiological diagnosis

Diagnostic agents / kits for microbiological diagnosis

Our products

Product category: DNA diagnosis kits, Auto-immune diseases, Diagnostics / kits for the gastro enterology, Equipment and systems for microbiological diagnosis/virology, Diagnostic agents / kits for microbiological diagnosis

Products

RESPIRATORY INFECTIONS
Recent pandemics H1N1 shows how important it is to be able to quickly develop rapid and highly reliable diagnostic tests. Diagenode team was among the first to release a kit in 2009.

GASTROENTERITIS INFECTIONS
Gastroenteritis Infections in the developed world are a major cause of hospitalisation in 'at risk' groups such as children and the elderly. Rapid detection is particularly necessary to avoid and control outbreaks.

SEXUALLY TRANSMITTED DISEASES
Screening of sexually transmitted diseases (STD) caused virus, bacteria and parasites is increasing in volume and importance.

HERPES VIRUSES
Cost effective and rapid screening of the Herpes simplex virus is critical for epidemiologic reasons.

MENINGITIS
We offer a rapid multiplex test for Meningitis pathogens (Neiserria and Streptococcus pneumoniae). Point of care tests will soon be introduced for screening of newborn babies.

OTHER PATHOGENS
Diagenode is continually developing new, cost effective, high quality Q-PCR tests for the detection of viruses, bacteria and parasites. We can also develop tests on your request.

DIAGENODE CONTROLS
We have designed and validated universal, DNA extraction and inhibition controls to run with all our kits giving you peace of mind with the results you obtain.

DIAGENODE DYES
Click here to learn more about running Diagenode Dyes on your Real-Time PCR instrumentation.

More Less

About us

Company details

Accurate and dependable diagnostics are essential to patient care. Diagenode’s IVD detection kits assure clinicians of infectious disease test results that are rapid, quantitative, cost-effective, and reliable.

Since 2003, Diagenode has provided highly trusted and cost-effective In Vitro Diagnostic (IVD) kits for viral, bacterial and parasites detection for a wide number of diseases. Using our combined expertise in nucleic acid technologies and IVD diagnostics, Diagenode offers a large unique portfolio of multiplex and monoplex real-time PCR (qPCR) detection kits.

In addition, Diagenode actively collaborates with medical and scientific experts in the field to develop and ensure the highest quality, clinically-validated tests. Diagenode is ISO9001 and ISO13485 and the kits are CE marked for In Vitro Diagnostic use.

The headquarter of Diagenode is based in Liege, Belgium, but has subsidiary’s in Sparta (New Jersey, USA), UK and France.

Advantages of Diagenode Diagnostics Nucleic Acid Based IVDs

  • CE certified
  • Clinically approved and validated kits assure highest quality
  • Quantitative and qualitative tests allows flexibility
  • Ease of use reduces clinical errors
  • Simple kit format eliminates need for viral, bacterial and parasites culture
  • Specific and sensitive for reliable results
  • Sample flexibility (swab, blood, and sputum)
  • Rapid time to results for more responsive patient care
  • Expert helpdesk

Diagenode Diagnostics Strengths

  • Our team of diagnostic experts collaborates closely with experts in the field.
  • We provide an open platform with kits adaptable to most IVD Platforms.
  • We offer competitive pricing on all IVD kits.

Kit Format

Diagenode’s kits contain:

  • Validated primers
  • Validated probes
  • Positive control for specific pathogen
  • DNA & RNA extraction control
  • qPCR inhibition control

Our kits are designed and validated for different qPCR platforms and different extraction protocols.

Diagenode Diagnostics kits do not contain a PCR master mix. Our kits, however, have been validated with most commonly used and commercially available master mixes. Upon request, Diagenode can provide suggestions for selecting the optimal master mix.

Company Focus

Diagenode’s tests accurately detect infectious pathogens both qualitatively and quantitatively and can produce timely test results allowing for better, cost-effective patient care.

Diagenode specialises in developing innovative kits for advanced molecular diagnostics. We specifically focus on producing highly sensitive and specific real-time PCR kits as qPCR has rapidly emerged as a standard for clinical molecular laboratories in diagnostic testing.

Our kits contain the full spectrum of materials required to obtain reliable and fast test results, including validated primers, probes, and controls for the detection and quantification of targeted pathogens.

In addition, we design, develop, and validate our kits in close collaboration with experts in the field.

More Less

Company data

Sales volume

1-9 Mio US $

Export content

max. 75%

Number of employees

50-99

Area of business

Diagnostics